BIOATLA, INC. Variable Lease, Cost
BIOATLA, INC. (BCAB) reported Variable Lease, Cost of $88.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- BIOATLA, INC. variable lease, cost for the quarter ending 2026-06-30 was $88.00K, a 59.07% decline year-over-year.
- BIOATLA, INC. variable lease, cost for the quarter ending 2026-03-31 was $119.00K, a 33.89% decline year-over-year.
- BIOATLA, INC. variable lease, cost for the quarter ending 2025-12-31 was $86.00K, a 45.91% decline year-over-year.
- BIOATLA, INC. variable lease, cost for the quarter ending 2025-09-30 was $87.00K, a 45.28% decline year-over-year.
- BIOATLA, INC. variable lease, cost for fiscal 2025 was $568.00K, a 17.56% decline from fiscal 2024.
- BIOATLA, INC. variable lease, cost for fiscal 2024 was $689.00K, a 26.65% increase from fiscal 2023.
- BIOATLA, INC. variable lease, cost for fiscal 2023 was $544.00K, a 18.26% increase from fiscal 2022.
- BIOATLA, INC. variable lease, cost for fiscal 2022 was $460.00K, a 10.16% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $88.00K 10-Q · filed 2026-08-13 | $207.00K 10-Q · filed 2026-08-13 | $293.00K derived: sum of 3 quarters · filed 2026-08-13 | $380.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $119.00K 10-Q · filed 2026-05-15 | $205.00K derived: sum of 2 quarters · filed 2026-05-15 | $292.00K derived: sum of 3 quarters · filed 2026-05-15 | $507.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $173.00K derived: sum of 2 quarters · filed 2026-03-31 | $388.00K derived: sum of 3 quarters · filed 2026-08-13 | $568.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $87.00K 10-Q · filed 2025-11-13 | $302.00K derived: sum of 2 quarters · filed 2026-08-13 | $482.00K 10-Q · filed 2025-11-13 | $641.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $215.00K 10-Q · filed 2026-08-13 | $395.00K 10-Q · filed 2026-08-13 | $554.00K derived: sum of 3 quarters · filed 2026-08-13 | $713.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $180.00K 10-Q · filed 2026-05-15 | $339.00K derived: sum of 2 quarters · filed 2026-05-15 | $498.00K derived: sum of 3 quarters · filed 2026-05-15 | $709.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $318.00K derived: sum of 2 quarters · filed 2026-03-31 | $529.00K derived: sum of 3 quarters · filed 2026-03-31 | $689.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $159.00K 10-Q · filed 2025-11-13 | $370.00K derived: sum of 2 quarters · filed 2025-11-13 | $530.00K 10-Q · filed 2025-11-13 | $672.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $211.00K 10-Q · filed 2025-08-07 | $371.00K 10-Q · filed 2025-08-07 | $513.00K derived: sum of 3 quarters · filed 2025-08-07 | $660.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $159.00K 10-Q · filed 2025-05-06 | $302.00K derived: sum of 2 quarters · filed 2025-05-06 | $449.00K derived: sum of 3 quarters · filed 2025-05-06 | $556.00K derived: sum of 4 quarters · filed 2025-05-06 | |
| 2023-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $290.00K derived: sum of 2 quarters · filed 2025-03-28 | $397.00K derived: sum of 3 quarters · filed 2025-03-28 | $544.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $147.00K 10-Q · filed 2024-11-07 | $254.00K derived: sum of 2 quarters · filed 2024-11-07 | $401.00K 10-Q · filed 2024-11-07 | $533.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $107.00K 10-Q · filed 2024-08-08 | $254.00K 10-Q · filed 2024-08-08 | $386.00K derived: sum of 3 quarters · filed 2024-08-08 | $518.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $147.00K 10-Q · filed 2024-05-14 | $279.00K derived: sum of 2 quarters · filed 2024-05-14 | $411.00K derived: sum of 3 quarters · filed 2024-05-14 | $475.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $264.00K derived: sum of 2 quarters · filed 2024-03-26 | $328.00K derived: sum of 3 quarters · filed 2024-03-26 | $460.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $132.00K 10-Q · filed 2023-11-07 | $196.00K derived: sum of 2 quarters · filed 2023-11-07 | $328.00K 10-Q · filed 2023-11-07 | $456.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $64.00K 10-Q · filed 2023-08-01 | $256.00K 10-Q · filed 2023-08-01 | $196.00K 10-Q · filed 2022-08-09 | $324.00K derived: sum of 3 quarters · filed 2023-08-01 | $452.00K derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $132.00K 10-Q · filed 2023-05-11 | $260.00K derived: sum of 2 quarters · filed 2023-05-11 | $388.00K derived: sum of 3 quarters · filed 2023-05-11 | $516.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $256.00K derived: sum of 2 quarters · filed 2023-03-23 | $384.00K derived: sum of 3 quarters · filed 2023-03-23 | $512.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $128.00K 10-Q · filed 2022-11-04 | $256.00K derived: sum of 2 quarters · filed 2022-11-04 | $384.00K 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $128.00K 10-Q · filed 2022-08-09 | $256.00K 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $128.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |